Try our beta test site

Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (HAART)

This study has been completed.
Gilead Sciences
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Andrew L. Mason, University of Alberta Identifier:
First received: April 25, 2011
Last updated: November 30, 2015
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)